key: cord-0803606-ycbv6tsq
authors: Song, Jukun; Li, Yamei; Huang, Xiaolin; Chen, Zhihong; Li, Yongdi; Liu, Chong; Chen, Zhu; Duan, Xiaofeng
title: Systematic Analysis of ACE2 and TMPRSS2 Expression in Salivary Glands Reveals Underlying Transmission Mechanism Caused by SARS‐CoV‐2
date: 2020-05-22
journal: J Med Virol
DOI: 10.1002/jmv.26045
sha: cfd39929b67821ff7be67b2673f78cb5252c78fb
doc_id: 803606
cord_uid: ycbv6tsq

OBJECTIVE: Coronavirus disease 2019 (COVID‐19) is a global pandemic that has caused severe health threats and fatalities in almost all communities. Studies have detected SARS‐CoV‐2 in saliva with a viral load that lasts for a long period. However, researchers are yet to establish whether SARS‐CoV‐2 can directly enter the salivary glands. Therefore, this study aimed to assess the presence of ACE2/TMPRSS2 expression in salivary glands using publicly available databases. METHODS: The distribution of ACE2 and TMPRSSs family in salivary gland tissue and other tissues was analyzed. The GTEx dataset was employed to explore the ACE2 and TMPRSS2 expression in various body organs and salivary glands in a healthy population. The single‐cell sequencing data for salivary gland samples (including submandibular salivary gland and parotid gland) from mice were collected and analyzed. The components and proportions of salivary gland cells expressing the key protease TMPRSSs family were analyzed. RESULTS: Transcriptome data analysis showed that ACE2 and TMPRSS2 were expressed in salivary glands. The expression levels of ACE2 and TMPRSS2 were marginal without significant differences in different age groups or between men and women. Single‐cell RNA sequence analysis indicated that TMPRSS2 was mainly expressed in salivary gland epithelial cells. CONCLUSION: We speculate that SARS‐CoV‐2 may be entered in salivary glands. This article is protected by copyright. All rights reserved.

Several unknown pneumonia cases were reported in Wuhan, Hubei, China in early December 2019 1, 2 . Sequencing of the respiratory tract samples from pneumonia patients confirmed that they had a respiratory virus that was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since then, Coronavirus disease 2019 (COVID-19) outbreaks have caused significant mortality and morbidity in China. By February 11, 2020, a total of 72,314 individuals were diagnosed with COVID-19, 1,023 death cases were recorded, and more than 21,675 suspected cases were reported in China. Currently, SARS-CoV-2 infected cases have been recorded in almost every part of the globe.

The COVID-19 pandemic has caused major illnesses and deaths and has been declared a global health emergency by the World Health Organization 3 . The spread of COVID-19 became unstoppable at the start of December 2019 and had attained the necessary epidemiological criteria to be declared a pandemic after having infected more than 100,000 people in 100 countries and regions. COVID-19 is currently a global pandemic that has severely affected economy [4] [5] [6] .

Severe acute respiratory syndrome coronavirus (SARS-CoV) entry into the cell is induced by the binding of viral spike (S) protein to cellular receptors triggered by Accepted Article host cell proteases. The S protein of SARS-CoV binds to angiotensin-converting enzyme 2 (ACE2) as the host cell receptor and is triggered by specific transmembrane serine proteases (TMPRSS) including TMPRSS2 and TMPRSS11D 7 . Current research classifies SARS-CoV-2 in the coronavirus family, β-CoV, which is closely related to SARS-CoV 8, 9 . The SARS-CoV-2 genome has an identical sequence with SARS-CoV 10, 11 . Therefore, the researchers have proposed that SARS-CoV-2 and SARS-CoV use the same receptors ACE2 and TMPRSS2 to gain entry into the cell. Besides, recent studies indicate that ACE2 and TMPRSS2 are potential host receptors for SARS-CoV-2 11, 12 . Multiple bioinformatic studies have identified potential routes for SARS-CoV-2 infection in respiratory, cardiovascular, digestive, salivary glands, and urinary systems [13] [14] [15] . A study by Xu et al reported that the ACE2 receptor for SARS-CoV-2 was highly expressed in epithelial cells of the oral mucosa specifically in tongue 16 . Clinical studies have also demonstrated that SARS-CoV-2 is present in saliva characterized by a higher viral load in the first weeks after onset of symptom and lasted for a long duration 17, 18 . However, it has not been established whether SARS-CoV-2 directly invade into the salivary glands. Therefore, this study employed a bioinformatic analysis to determine the distribution of ACE2 and TMPRSS2 in salivary glands.

This study explored the distribution and expression of ACE2 and TMPRSSs family in various body tissues but mainly focused on the salivary gland. The bulk RNA-seq profiles for normal salivary glands were collected from the Genotype-Tissue Expression (GTEx) project The GO/KEGG terms between the highly ACE2 expressed group and the lowly ACE2 expressed group was identified. The significant enrichment pathway was determined based on FDR < 0.05. This article is protected by copyright. All rights reserved.

Several SARS-CoV-2 infected patients exhibited potential target organs including the lung, kidney, testis, tears, and oral mucosa. We explored the vulnerable organs to SARS-CoV-2 in the healthy population. Data from the GTEx project indicated that ACE2 was highly expressed in the testis, small intestine, and adipose tissue whereas, the spleen and blood showed lower expression levels. Besides, the TMPRSS2 was highly expressed in the pituitary gland and prostate, whereas, the spleen, heart, adipose tissue, the blood showed lower expression levels. Both ACE2 and TMPRSS2 were moderately expressed in oral mucosa and salivary glands ( Figure 1A, B) . The heatmap analysis showed that the TMPRSSs family and ACE2 was expressed across the organs ( Figure 1C ). The findings reported an increase in ACE2 and TMPRSSs family gene expression. The ACE2 expression level was positively correlated with TMPRSS2 in most organs including the salivary glands, small intestine, and kidney. Contrarily, a negative correlation between ACE2 and TMPRSS2 was observed in the fallopian tube, breast, and prostate (Supplementary Table 2, Figure 2A ). In the salivary glands, we reported a positive correlation (Pearson's correlation coefficient R = 0.35, P =0.01, N = 55, Figure 2B ) whereby an increase in TMPRSS2 expression level by 1 log2 (RPKM) value increased ACE2 expression level by ~ 0.35 log2 (RPKM) value.

In this study, we compared and analyzed the co-expression levels of ACE2 and TMPRSS2 in humans. The expression levels for ACE2 and TMPRSS2 was significantly altered between the male and female populations in blood, brain, breast, heart, esophagus, and skeletal muscle organ ( Figure 3A, B) . A marginal Accepted Article but not significant difference in ACE2 or TMPRSS2 expression was observed in different age groups, or between men and women. This result was consistent with the epidemiological characteristics of over 70,000 cases released by the Chinese Centers for Disease Control and Prevention on February 11, 2020 (with a 0.99: 1 ratio in Wuhan and 1.06: 1 in the whole country) 22 . The level of ACE2 and TMPRSS2 in the salivary glands was relatively higher in the younger population compared to the elderly population ( Figure 3C, D) . However, no statistical significance was observed in expression levels of ACE2 and TMPRSS2 based on age disparity.

The correlation analysis of the salivary gland tissues determined the co-expression relationship between the ACE2 and TMPRSSs family. Through Pearson's correlation analysis, ACE2 was reported to correlate with several TMPRSS genes including TMPRSS2, TMPRSS5, TMPRSS3, and TMPRSS7 ( Figure 4) .

The gene expression profiles of 55 healthy salivary gland samples were obtained from the GTEX dataset to examine the potential biological processes associated with ACE2 and TMPRSS2. Based on the median for ACE2 and TMPRSS2 expression levels, samples were divided into higher expression group and lower expression group. The GSEA was conducted to determine the ACE2/TMPRSS2 related functional enrichment categories. The enrichment of GO terms mainly occurred in the U4 snRNA binding, negative regulation of phospholipid metabolic process, and in the ribosome ( Figure 5A, B) . Higher expression of ACE2 and TMPRSS2 potentially activated the ribosomal pathway which is associated with coronavirus as reported in several studies 23, 24 . Ribosome was identified to be involved in the synthesis of viral RNA and proteins, and virus replication. The This article is protected by copyright. All rights reserved.

KEGG analysis revealed that asthma, spliceosome, and autophagy were activated in the higher expression group (Figure 5C, D) . Notably, previous studies have reported that the importance of the process of autophagy in virus entry and replication has been increasingly understood 25, 26 .

From the scRNA-seq data, expression level for ACE2 was mostly recorded at 0.

ACE2 was filtered after the initial quality check thereby assessing the expression pattern for TMPRSS2 in the mouse salivary glands. We analyzed the published scRNAseq dataset for submandibular and parotid glands. In the mouse submandibular gland dataset, a total of 1,031 cells attained standard quality control and were retained for subsequent analyses. Based on the expression of a set of markers, eight distinct cell populations were identified including ductal cell, stem cell/mesenchymal cell, acinar cell, myoepithelial cell, basal cell, and immune cell ( Figure 6A ). It was reported that TMPRSS2 was highly localized in the ductal cell and basal cell ( Figure 6B ). Contrarily, TMPRSS2 expression was not observed in immune cells. In the mouse parotid gland dataset, a total of 1,276 cells attained standard quality control and were retained for further analyses.

Single cells were grouped into six sub-clusters based on the canonical markers and cell classification in the literature. We reported that TMPRSS2 was highly expressed in the ductal cell, basal cell, and acinar cell ( Figure 7A, B) whereas, no expression was observed in the immune cell.

Since the parotid and submandibular glands have similar tissue, we merged the two scRNA-seq data into one dataset. A total of 1,492 cells attained standard quality control and were retained for further analyses. Based on the expression of a set of markers, 11 distinct cell populations were identified including ductal cell, stem cell/mesenchymal cell, acinar cell, myoepithelial cell, basal cell, and immune cell ( Figure 8A,B) . The results implicated that TMPRSS2 is highly expressed in This article is protected by copyright. All rights reserved.

the submandibular salivary gland than in the parotid gland ( Figure 8C ). TMPRSS2 was highly expressed in ductal and acinar cells in parotid glands whereas, in submandibular glands, it was highly expressed in the ductal and myoepithelial cells ( Figure 8D ). These observations indicated that TMPRSS2 is expressed on the surface of salivary gland cells, therefore, SARS-CoV-2 can potentially gain entry into the salivary glands.

In the last two decades, coronaviruses have caused two severe pandemics Many studies have focused on lung damage as a result of SARS-CoV-2 infection, however, infection of the salivary glands has not been explored. Therefore, we explored the distribution of ACE2 and TMPRSSs gene expression levels in a healthy population. Besides, the differences in ACE2 and TMPRSS2 gene expression were determined based on age and gender through the analysis of transcriptome data. Although higher expression of ACE2 and TMPRSS2 was observed in the female population, no statistical significance was determined. This

is consistent with a previous report that indicated gender disparity was not detected. Also, the ACE2/TMPRSS2 expression level in the salivary glands in the younger population was marginal higher than in the elderly population, but no statistically significance was observed.

Recent studies have reported the presence of SARS-CoV-2 in saliva with a viral load that lasts for a long duration. A report by Lu et al indicated that SARS-CoV-2 can be transmitted through the mucous membranes including saliva, conjunctival secretions, and tears 29 . Several reports on ophthalmologists getting infected through routine diagnosis and treatment have also been published.

Moreover, a clinical study that analyzed 2019-nCoV nucleic acid in saliva samples from COVID-19 patients reported potential SARS-CoV-2 entrance into the salivary glands 17 . Therefore, it is vital to perform an in-depth study on saliva as a SARS-CoV-2 transmission pathway. Findings from the scRNA-seq datasets indicate that TMPRSS2 is superficially expressed on the salivary gland cells. Of note, TMPRSS2 is highly expressed in the ductal cell compared to the acinar and basal cells. Therefore, we speculated that salivary glands may act as a reservoir for SARS-CoV-2 thereby increasing viral load in the saliva.

In addition, previous studies reported that 99% of patients did not have clinical manifestations of oral human papillomavirus (HPV). However, HPV DNA was detected in 81% in samples from oral mucosa and anti-HPV IgA was detected in oral mucosa samples 30 . Like HPV infection, SARS-CoV-2 infection is characterized by a few symptoms from salivary gland injury. Besides, a recent pilot experiment showed that 4 out of 62 stool specimens were positive for SARS-CoV-2 and an additional 4 patients tested via rectal swabs had SARS-CoV-2 in the gastrointestinal tract and saliva 31 . Therefore, findings from this study confirm that in addition to the respiratory tract and lung organs, SARS-CoV-2 can enter other organs, such as saliva and gastrointestinal tract. This article is protected by copyright. All rights reserved.

Conclusively, this study used the transcriptome data to analyze the expression levels for ACE2 and TMPRSS2 in salivary glands among a healthy population.

Results from the scRNA-seq analysis accurately located the expression and distribution of TMPRSS2 in salivary glands. TMPRSS2 is mainly expressed in salivary gland epithelial cells. These findings confirm that human salivary glands have a host cell receptor for SARS-CoV-2. This implies that the virus might gain entry into the salivary glands. However, the underlying mechanism remains unclear and should further be explored.

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Novel Coronavirus Pneumonia Emergency Response Epidemiology Team

Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern

Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures

An Epidemiological Study on COVID-19: A Rapidly Spreading Disease

From Containment to Mitigation of COVID-19 in the US

A Novel Coronavirus from Patients with Pneumonia in China

COVID-19 (Novel Coronavirus 2019) -recent trends

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting Accepted Article enzyme 2 and infection can be blocked by soluble receptor

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Consistent detection of 2019 novel coronavirus in saliva

Genetic and scRNA-seq Analysis Reveals Distinct Cell Populations that Contribute to Salivary Gland Development and Maintenance

Transcriptomic and Single-Cell Analysis of the Murine Parotid Gland

Restoring function in exhausted CD8 T cells during chronic viral infection

Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling

SARS coronavirus protein nsp1 disrupts localization of Nup93 from the nuclear pore complex

Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy

SARS and MERS: recent insights into emerging coronaviruses

COVID-19 and Italy: what next? The Lancet

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

Asymptomatic oral human papillomavirus (HPV) infection in women with a histopathologic diagnosis of genital HPV

Clinical Characteristics of Coronavirus Disease 2019 in China

None.

The authors declare that they have no competing interests.

The works was supported by Guiyang Science and Technology Bureau